Evidence map›Paper›PMID 36062478›Full record

ArticleACS infectious diseases2022

Broad-Spectrum Extracellular Antiviral Properties of Cucurbit[

Luke M Jones, Elana H Super, Lauren J Batt, Matteo Gasbarri, Francesco Coppola, Lorraine M Bhebhe, Benjamin T Cheesman, Andrew M Howe, Petr Král, Roger Coulston and 1 more

Abstract read
In one paragraph

Article in ACS infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Bioactive Polysulfate-Based Nano-Assemblies Against Virus Infection.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Pillararenes as Promising Carriers for Drug Delivery.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Luke M JonesDepartment of Materials and The Henry Royce Institute, The University of Manchester, Manchester M19 3PL, United Kingdom.
Elana H SuperDepartment of Materials and The Henry Royce Institute, The University of Manchester, Manchester M19 3PL, United Kingdom.
Lauren J BattDepartment of Materials and The Henry Royce Institute, The University of Manchester, Manchester M19 3PL, United Kingdom.
Matteo GasbarriInstitute of Materials, Interfaculty Bioengineering Institute, MXG 030 Lausanne, Switzerland.ORCID 0000-0002-8469-5369
Francesco CoppolaDepartment of Chemistry, University of Illinois at Chicago, Chicago, Illinois 60607, United States.ORCID 0000-0002-2429-204X
Lorraine M BhebheDepartment of Materials and The Henry Royce Institute, The University of Manchester, Manchester M19 3PL, United Kingdom.
Benjamin T CheesmanAqdot Limited, Iconix Park, London Road, Pampisford, Cambridge CB22 3EG, United Kingdom.
Andrew M HoweAqdot Limited, Iconix Park, London Road, Pampisford, Cambridge CB22 3EG, United Kingdom.
Petr KrálDepartment of Chemistry, University of Illinois at Chicago, Chicago, Illinois 60607, United States.
Roger CoulstonAqdot Limited, Iconix Park, London Road, Pampisford, Cambridge CB22 3EG, United Kingdom.
Samuel T JonesDepartment of Materials and The Henry Royce Institute, The University of Manchester, Manchester M19 3PL, United Kingdom.ORCID 0000-0002-3907-0810

Funding

Biotechnology and Biological Sciences Research Council BB/T008725/1
6 · The paper itself

Abstract

Viruses are microscopic pathogens capable of causing disease and are responsible for a range of human mortalities and morbidities worldwide. They can be rendered harmless or destroyed with a range of antiviral chemical compounds. Cucurbit[

Indexed as

COVID-19DisinfectantsMacrocyclic CompoundsAmino AcidsAntiviral AgentsBridged-Ring CompoundsHumansImidazolesMembrane ProteinsSARS-CoV-2Amino AcidsAntiviral AgentsBridged-Ring CompoundsDisinfectantsImidazolesMacrocyclic CompoundsMembrane Proteinsantiviralcucurbiturildose−responsemacrocyclevirucidalvirustatic

Identifiers

PMID36062478
PMCPMC9578052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.